levodopa has been researched along with sq-23377 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenci, S; Indiveri, F; Lotti, G; Musso, NR | 1 |
| Cao, X; Chen, G; Han, C; Ma, K; Nie, S; Papa, SM; Wang, T; Xiong, N; Xu, Y; Zhang, Z | 1 |
2 other study(ies) available for levodopa and sq-23377
| Article | Year |
|---|---|
Acetylcholine-induced, calcium-dependent norepinephrine outflow from peripheral human lymphocytes.
Topics: Acetylcholine; Adult; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Gallopamil; Humans; Ionomycin; Levodopa; Lymphocytes; Male; Norepinephrine; Tyrosine; Veratridine | 1998 |
Intrastriatal injection of ionomycin profoundly changes motor response to l-DOPA and its underlying molecular mechanisms.
Topics: Animals; Antiparkinson Agents; Calcineurin; Calcium Ionophores; Corpus Striatum; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Glutamic Acid; Ionomycin; Levodopa; Male; MAP Kinase Signaling System; Parkinsonian Disorders; Phosphorylation; Proto-Oncogene Proteins c-fos; Random Allocation; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2017 |